<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T06:36:52Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/216159" metadataPrefix="qdc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/216159</identifier><datestamp>2025-12-04T19:30:40Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478908</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Lipids in the tumor microenvironment: immune modulation and metastasis</dc:title>
   <dc:creator>Pascual, Gloria</dc:creator>
   <dc:creator>Aznar Benitah, Salvador</dc:creator>
   <dc:subject>Tumors</dc:subject>
   <dc:subject>Lípids</dc:subject>
   <dc:subject>Tumors</dc:subject>
   <dc:subject>Lipids</dc:subject>
   <dcterms:abstract>Tumor cells can undergo metabolic adaptations that support their growth, invasion,&#xd;
and metastasis, such as reprogramming lipid metabolism to meet their energy&#xd;
demands and to promote survival in harsh microenvironmental conditions,&#xd;
including hypoxia and acidification. Metabolic rewiring, and especially alterations in&#xd;
lipid metabolism, not only fuel tumor progression but also influence immune cell&#xd;
behavior within the tumor microenvironment (TME), leading to immunosuppression&#xd;
and immune evasion. These processes, in turn, may contribute to the metastatic&#xd;
spread of cancer. The diverse metabolic profiles of immune cell subsets, driven by&#xd;
the TME and tumor-derived signals, contribute to the complex immune landscape in&#xd;
tumors, affecting immune cell activation, differentiation, and effector functions.&#xd;
Understanding and targeting metabolic heterogeneity among immune cell subsets&#xd;
will be crucial for developing effective cancer immunotherapies that can overcome&#xd;
immune evasion mechanisms and enhance antitumor immunity.</dcterms:abstract>
   <dcterms:issued>2024-10-31T13:53:30Z</dcterms:issued>
   <dcterms:issued>2024-10-31T13:53:30Z</dcterms:issued>
   <dcterms:issued>2024-09-26</dcterms:issued>
   <dcterms:issued>2024-10-31T12:42:39Z</dcterms:issued>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:relation>Reproducció del document publicar a: https://doi.org/10.3389/fonc.2024.1435480</dc:relation>
   <dc:relation>Frontiers In Oncology, 2024, 14,</dc:relation>
   <dc:relation>https://doi.org/10.3389/fonc.2024.1435480</dc:relation>
   <dc:rights>cc by (c) Pascual, Gloria et al., 2024</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:source>Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))</dc:source>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>